The proposed Network has the potential to improve the health outcomes of most Australians through improved chemotherapy for cancer treatment, improved radiopharmaceuticals for the diagnosis and treatment of disease, more effective treatments of a range of degenerative diseases and many other contributions to improved health care. Such contributions are not only of importance in promoting and maintaining good health, but have an enormous potential economic benefit to Australia through reduced health costs and the growth of Australia's pharmaceutical industry.
Specific short-term economic and social impacts include:
Longer-term outcomes include:
Mechanisms for Capturing National Benefits
The network brings together researchers involved in fundamental and applied sciences with clinicians manufacturers and investors on a national basis and provides links with major international consortiums in order to optimise the opportunities for penetration of products and expertise into clinic and manufacturing industry. Thus it has all of the ingredients required to capture the research for National Benefits.
Apart from capturing the commercial and health care benefits, there will be a mentoring program for early career researchers and students, which will involve access to scientific exchanges, access to major facilities and the opportunity to join major collaborative research programs (including international programs) that might not otherwise be available to these researchers. This is essential to provide the expertise required to maintain a vibrant expansion of the program.